Lidocaína/Adrenalina Aguettant

Lidocaine hydrochloride, the active ingredient in Lidocaína/Adrenalina Aguettant, is a local anesthetic combination presented as a sterile injectable solution for epidural, infiltration and perineural use. It provides local anesthesia for surgical procedures and related interventions. GNH USA supplies Lidocaína/Adrenalina Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lidocaína/Adrenalina Aguettant is a local anesthetic combination used in procedures that require regional nerve blockade or surface anesthesia. - Surgical procedures: provides rapid onset and prolonged local anesthesia for incision and excision. - Epidural analgesia: extends pain relief during labor or postoperative periods. - Infiltration anesthesia: numbs tissue directly at the surgical site. - Perineural (nerve block) anesthesia: blocks transmission along targeted nerves for limb or extremity surgery.

Adverse reactions may occur following administration of the lidocaine/epinephrine combination.

Common Side Effects: - Pain or irritation at the injection site - Transient tachycardia - Mild hypertension - Nausea or vomiting - Dizziness or light‑headedness - Local swelling or erythema

Serious or Rare Side Effects: - Severe arrhythmias or cardiac arrest - Myocardial infarction - Anaphylactic or severe allergic reaction - Seizures or central nervous system toxicity - Profound hypotension - Respiratory depression

Before using Lidocaína/Adrenalina Aguettant, clinicians should consider several safety measures. - Cardiovascular assessment: evaluate heart rate, blood pressure, and arrhythmia risk. - Hypertension caution: use lower concentrations in patients with uncontrolled high blood pressure. - Hypersensitivity: avoid in individuals with known allergy to lidocaine, epinephrine, or related compounds. - Systemic toxicity monitoring: observe for signs of CNS or cardiac toxicity during and after injection. - Hepatic impairment: adjust dose or monitor closely in patients with reduced liver function. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Lidocaína/Adrenalina Aguettant may interact with other medications, requiring careful review.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs) - Non‑selective beta‑blockers - Tricyclic antidepressants - Other local anesthetics administered concurrently - Sympathomimetic agents (e.g., phenylephrine)

Moderate Interactions (Monitor Closely): - Cimetidine or other H2‑blockers - Calcium channel blockers - Diuretics that affect electrolyte balance - Anti‑arrhythmic drugs - Non‑steroidal anti‑inflammatory drugs (NSAIDs)